Trinity Biotech, the Irish-founded medical diagnostics company, has agreed a deal to sell its life sciences supply business to Biosynth for $30 million .
The Nasdaq-listed firm said the deal for its Fitzgerald Industries businesses, is expected to close by the end of the month. Bray-headquartered Trinity develops, manufactures and markets diagnostic systems for the point-of-care and clinical laboratory segments of the diagnostic market. Its products are sold in more than 110 countries, and ...
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: